Avid Bioservices Inc (CDMO)

[stoneroad]

Not necessarily, the Feuerstein-Ratain Rule would indicate that unless we get a SP move to reflect a MC in excess of $300 million, it is highly likely that SUNRISE will be a failure (based upon prior biotech experience). There is still time, but we should start to see a move higher if in fact Bavi is all that.

http://www.thestreet.com/story/12696926/1/the-feuerstein-ratain-rule-update-still-perfect-predicting-small-cap-cancer-drug-failure.html